Pharma startup Quris aims to use a 'patient on a chip' to target drug delivery

Nobel Laureate, Aaron Ciechanover, is one of several notable names behind pharma startup Quris. The company aims to bring together artificial intelligence, the industry's vast knowledge of the human genome, and the concept of the "patient on a chip" to improve the effectiveness of drug delivery. Last month, the startup announced the launch of its AI platform and a $9 million seed round, led by Moshe Yanai (the mind behind EMC Symmetrix) and Dr. Judith Richter, and Dr. Jacob Richter (founders of Medinol, which has sold more than 2 million cardiovascular stents). Ciechanover, as well as Moderna cofounder, Robert Langer, are among Quris' noteworthy advisers. For decades, medical research has successfully cured cancer and treated rare diseases in innumerable quantities of mice – but has not done so as frequently in humans.